# Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging

> **NCT04400292** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 90 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **OTHER:** Injection of indocyanine green (ICG)dye
- **DEVICE:** Near-Infrared Image-Guided
- **PROCEDURE:** Sentinel Lymph Node (SLN) mapping

## Key facts

- **NCT ID:** NCT04400292
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-05-20
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04400292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04400292, "Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04400292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*